Browsing by Author "Bilir, Cemil"
Now showing items 1-4 of 4
-
Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of anatolian Society of medical oncology (ASMO)
Aydın, Dinçer; Şendur, Mehmet Ali; Kefeli, Umut; Ünal, Olçun Umut; Taştekin, Didem; Akyol, Murat; Tanrıkulu, Eda; Çiltaş, Aydin; Ustaalioğlu Bala, Başak; Dede Şener, Didem; Esbağ, Onur; İnal, Ali; Bilir, Cemil; Bilici, Ahmet; Harputlu, Hakan; Berk, Veli; Sevinç, Alper; Özdemir Yıldırım, Nuriye; Yıldırım, Emre; Sonkaya, Alper; Ustaoğlu, Mehmet Ali; Gümüş, Mahmut (Imprimatur Publications, 2016)Purpose: Small bowel adenocarcinoma (SBA) is a rare tumor of the gastrointestinal system with poor prognosis. Since these are rarely encountered tumors, there are limited numbers of studies investigating systemic treatment ... -
Is change in hemoglobin level a predictive biomarker of tyrosine kinase efficacy in metastatic renal cell carcinoma? A Turkish oncology group study
Bilir, Cemil; Yıldız, İbrahim; Bilici, Ahmet; Uçar, Mahmut; Berk, Veli; Yıldız, Yaşar; Yazıcı, Ozan; İnanç İmamoğlu, Gökşen; Karadurmuş, Nuri; Pilancı, Kezban Nur; Arpacı, Erkan; Tanrıverdi, Özgür; Karcı, Ebru; Temiz, Süleyman; Nayır, Erdinç; Oktay, Esin; Dal, Pınar; Petekkaya, İbrahim; Varım, Ceyhun; Cinemre, Hakan (Taylor & Francis Inc., 2017)Background: There are insufficient predictive markers for renal cell carcinoma (RCC). Methods: A total of 308 metastatic RCC patients were analyzed retrospectively. Results: The increased hemoglobin (Hb) group had significantly ... -
Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer
Kefeli, Umut; Arslan, Çağatay; Yıldırım, Mahmut Emre; Işıkdoğan, Abdurrahman; Karadurmuş, Nuri; Karabulut, Bülent; Çubukçu, Erdem; Çiçin, İrfan; Yalçın, Şuayib; Türk, Hacı Mehmet; Bilir, Cemil; Karaca, Mustafa; Artaç, Mehmet; Şendur, Mehmet Nahit; Alacacıoğlu, Ahmet; Tanrıkulu Şimşek, Eda; Dane, Faysal; Bilici, Ahmet; Çevik, Duygu; Gümüş, Mahmut (Lippincott Williams & Wilkins, 2021)Background: Efficacy of anti-angiogenic and anti-EGFR agents has been demonstrated metastatic colorectal cancer (mCRC). Real-world evidence is especially important to detect the findings of patients outside of clinical ... -
Surgical, pathological and clinical features of advanced collorectal cancers with metastasectomy. "Onco-Colon Turkey Registry" real-life data
Karadurmuş, Nuri; Yıldırım, Emre; Yalçın, Şuayib; Gümüş, Mahmut; Bilir, Cemil; Çubukçu, Erdem; Tanrıkulu Şimşek, Eda; Arslan, Çağatay; Dane, Faysal; Çelik, Sinemiş; Bilici, Ahmet; Şendur, Mehmet Ali Nahit; Öven, Başak Bala; Işıkdoğan, Abdurrahman; Türk, Hacı Mehmet; Karaca, Mustafa; Karabulut, Bülent; Özçelik, Melike; Çevik, Duygu; Kefeli, Umut (Lippincott Williams & Wilkins, 2022)Background: The contribution of metastasectomy to progression-free survival (PFS) and overall survival (OS) in patients (pts) with advanced stage colorectal cancer has been demonstrated in clinical trials. However, clinical ...
